BVNKF - WHO declares monkeypox outbreak a global health emergency
- The World Health Organization (WHO) designated the current monkeypox outbreak a public health emergency of international concern (PHEIC) on Saturday.
- PHEIC designation is WHO's highest level of warning, previously issued for the COVID-19 pandemic and Ebola. The decision follows a meeting of the WHO’s Emergency Committee.
- "Under the International Health Regulations, I am required to consider five elements in deciding whether an outbreak constitutes a public health emergency of international concern," Director-General of the WHO, Tedros Adhanom Ghebreyesus noted.
- Vaccine developers for monkeypox: Bavarian Nordic ( OTCPK:BVNKF ) ( OTCPK:BVNRY ), Emergent BioSolutions ( EBS ), Chimerix ( CMRX ).
- Developers of therapeutics for monkeypox: GeoVax Labs ( GOVX ), SIGA Technologies ( SIGA ) and Tonix Pharmaceuticals ( TNXP ).
- Monkeypox test makers: Co-Diagnostics ( CODX ), Roche ( OTCQX:RHHBY ) ( OTCQX:RHHBF ), Abbott Laboratories ( NYSE: ABT )
For further details see:
WHO declares monkeypox outbreak a global health emergency